Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859))

N. I. Lindeman, P. T. Cagle, M. B. Beasley, D. A. Chitale, S. Dacic, G. Giaccone, R. B. Jenkins, D. J. Kwiatkowski, J. S. Saldivar, J. Squire, E. Thunnissen, M. Ladanyi

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (Journal of Thoracic Oncology (2013) 8 (823-859))'. Together they form a unique fingerprint.